agilon health inc. Common Stock (AGL)

FairStock Score: 30/100 — RISKY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for consistent earning power, a durable competitive advantage, and a price that leaves room for error. agilon health does not yet meet that standard. It provides a platform for senior primary care on a per-member per-month basis, which sounds recurring, but the financial record shows little durable profitability. Revenue was $1.5B in fiscal Q2 2026, the quarter ended 2026-06-30, with net income of $18.0M; fiscal Q1 2026, ended 2026-03-31, had net income of $48.9M. Those are encouraging turns. Yet FY2025, ended 2025-12-31, produced a net loss of $391.3M on $5.9B of revenue, after losses of $260.2M in FY2024 and $262.6M in FY2023. FairStock's Lynch category is none because of losses in each of the last four years. The balance sheet has one clear positive: debt-to-equity of 0.15. But trailing free cash flow was -$106.0M, a FairStock FCF yield of -24.6%, and Altman Z-score was -0.45. FairStock's P/E of -5.64 and ROE of -78.94% confirm the absence of earnings power. At the $85.90 close on 2026-10-13, FairStock's P/B is 6.34, which is not cheap against negative profits and cash burn. The FairStock score is 30/100, and Piotroski is 4/9. The recent quarters hint at a turnaround, but the top line alone does not prove a moat. I would want several years of positive net income and free cash flow before treating this as a value opportunity. Until then, the margin of safety is thin.

In plain English: agilon health works with primary care doctors to manage care for seniors, mainly through a per-person monthly fee. It has grown revenue to billions and even had small profits in two recent quarters, but it lost money in each of the last four years and used cash over the last year. At the recent price of $85.90, the stock looks expensive compared with those weak profits and cash losses.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer